- Joined
- Nov 17, 2011
- Messages
- 51
- Reaction score
- 4
Please ask yourself this. How many people are diagnosed and receive treatment for cancer in the United States and the each year?
If you do not know very much about the domain names described below. Take the time to do some research online. You will discover a lot in a few minutes
Before a patient (that is human and animal) can receive treatment, the medical professional treating the patient has to find or locate the cancer. A term used by medical professionals is Tumor Localization. There are many, many methods that may fall under
Tumor Localization. To a company or organization that wanted to provide services and or support to those diagnosed with and treating patients with cancer, www.TumorLocalization.com could be very valuable.
An item used to rule out, treat or track the progress is radiation. Most of you know what Nuclear Medicine is. Here is some information that may be helpful. The other domains that I am submitting .
PETRADIOPHARMACEUTICALS.COM , [FONT="]F18RADIOPHARMACEUTICALS.COM,
[/FONT]
[FONT="]F-18RADIOPHARMACEUTICALS.COM a more recent use of PET is PEM or Positron Emission Mammography. Please appraise PEMSCAN.COM[/FONT]
Tumor Localization
PET (Positron Emission Tomography) is both a medical and research tool. It is used heavily in clinical oncology (medical imaging of tumors and the search for metastases), and for clinical diagnosis of certain diffuse brain diseases such as those causing various types of dementias. PET is also an important research tool to map normal human brain and heart function.
PET is also used in pre-clinical studies using animals, where it allows repeated investigations into the same subjects. This is particularly valuable in cancer research, as it results in an increase in the statistical quality of the data (subjects can act as their own control) and substantially reduces the numbers of animals required for a given study.
Fluorodeoxyglucose ([SUP]18[/SUP]F) or fludeoxyglucose ([SUP]18[/SUP]F) (INN), commonly abbreviated [SUP]18[/SUP]F-FDG or FDG, is a radiopharmaceutical used in the medical imaging modality positron emission tomography (PET). Chemically, it is 2-deoxy-2-([SUP]18[/SUP]F)fluoro-D-glucose, a glucose analog, with the positron-emitting radioactive isotope fluorine-18 substituted for the normal hydroxyl group at the 2' position in the glucose molecule.
If there are any questions please email me at [email protected]
If you do not know very much about the domain names described below. Take the time to do some research online. You will discover a lot in a few minutes
Before a patient (that is human and animal) can receive treatment, the medical professional treating the patient has to find or locate the cancer. A term used by medical professionals is Tumor Localization. There are many, many methods that may fall under
Tumor Localization. To a company or organization that wanted to provide services and or support to those diagnosed with and treating patients with cancer, www.TumorLocalization.com could be very valuable.
An item used to rule out, treat or track the progress is radiation. Most of you know what Nuclear Medicine is. Here is some information that may be helpful. The other domains that I am submitting .
PETRADIOPHARMACEUTICALS.COM , [FONT="]F18RADIOPHARMACEUTICALS.COM,
[/FONT]
[FONT="]F-18RADIOPHARMACEUTICALS.COM a more recent use of PET is PEM or Positron Emission Mammography. Please appraise PEMSCAN.COM[/FONT]
Tumor Localization
PET (Positron Emission Tomography) is both a medical and research tool. It is used heavily in clinical oncology (medical imaging of tumors and the search for metastases), and for clinical diagnosis of certain diffuse brain diseases such as those causing various types of dementias. PET is also an important research tool to map normal human brain and heart function.
PET is also used in pre-clinical studies using animals, where it allows repeated investigations into the same subjects. This is particularly valuable in cancer research, as it results in an increase in the statistical quality of the data (subjects can act as their own control) and substantially reduces the numbers of animals required for a given study.
Fluorodeoxyglucose ([SUP]18[/SUP]F) or fludeoxyglucose ([SUP]18[/SUP]F) (INN), commonly abbreviated [SUP]18[/SUP]F-FDG or FDG, is a radiopharmaceutical used in the medical imaging modality positron emission tomography (PET). Chemically, it is 2-deoxy-2-([SUP]18[/SUP]F)fluoro-D-glucose, a glucose analog, with the positron-emitting radioactive isotope fluorine-18 substituted for the normal hydroxyl group at the 2' position in the glucose molecule.
If there are any questions please email me at [email protected]
